Plus Venture Capital (+VC)

Plus Venture Capital, branded +VC, is a Manama-based MENA seed fund founded by ex-500 Startups partners that has built a reputation for high-velocity early-stage deployment across the Gulf and broader region. The fund writes Seed and Series A checks generally in the $250k to $1M range and is sector-broad, with active interest in scalable SaaS, B2B platforms, and AI-enabled software. Within healthcare, the relevant surfaces are digital health, telemedicine, pharmacy and clinic SaaS, healthcare workforce software, and AI applications layered onto regional health insurance and provider workflows. Founders pursuing biotech, MedTech with regulatory clearance pathways, or capital-intensive care delivery should look at later-stage MENA capital. The right founder for +VC is a technical operator targeting MENA enterprise or prosumer markets, comfortable with rapid deployment and a fund that runs more like a high-volume seed shop than a concentrated boutique. The pace is a feature: +VC tends to make decisions quickly when the thesis fits, syndicates with regional and global seed funds, and helps founders stitch together the messy first round. Geographic advantage is its MENA breadth, with relationships across UAE, Saudi Arabia, Egypt, Jordan, and Bahrain, and an LP base that includes regional family offices and operators who can open commercial doors. Best entry is a warm intro from a portfolio founder or a known regional co-investor; cold outreach is read but standards are sharper than the deployment pace suggests. Lead the pitch with a credible MENA wedge, real customer conversations rather than aspirational LOIs, and a sober view on cross-border expansion across the Gulf, given that each market has its own healthcare regulator, payer system, and cultural dynamics. AI founders should be ready to discuss Arabic-language NLP, data localization rules in Saudi Arabia and UAE, and how clinical or claims data flows are structured. Caveats are real. At $250k to $1M check sizes, +VC is a co-investor in most rounds rather than a sole lead, so founders need to assemble a syndicate that includes a deeper-pocketed lead for the Series A. Ask the fund directly about reserves, follow-on cadence, and which co-investors they bring in for healthcare deals specifically. The 500 Startups DNA also implies a portfolio-construction philosophy that values breadth, so do not expect the depth of operational support that a concentrated fund provides; treat +VC as an excellent regional connector and a fast initial check, and pair it with a partner who will work the portfolio with you week to week. With those expectations set, +VC is one of the more pragmatic seed checks available in MENA today.